Physician profile
Vincent C Traynelis
NPI 1487647517
$1,756,330.13
in general payments reported to CMS, 2019-2025
7 companies · $299K in 2025
The $299K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515K · 2020: $257K · 2021: $188K · 2022: $123K · 2023: $157K · 2024: $218K · 2025: $299K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $654K · Consulting Fee: $15K · Food and Beverage: $2,434 · Travel and Lodging: $1,753 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $654,355.24 |
| Consulting Fee | $14,620.00 |
| Food and Beverage | $2,433.99 |
| Travel and Lodging | $1,753.02 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $770.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $744,282.92 | 2019-2020 | |
| Globus Medical, INC. | $478,776.51 | 2019-2025 | Reline |
| Medtronic, INC. | $354,002.31 | 2021-2025 | Venture Anterior Cervical Plate System, Infinity Occipitocervical Upper Thoracic System, Prestige Lp Cervical Disc System |
| Nuvasive, INC. | $178,968.39 | 2019-2023 | Reline, Pcm, Xlif |
| Cerapedics INC. | $191.45 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $98.74 | 2022 | |
| Orthofix Medical, INC. | $9.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Traynelis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.